title: From cell regulation to patient survival: 2nd Cancer Immunotherapy and Immunomonitoring (CITIM) meeting, Budapest, 2-5 May 2011.
authors.affiliation: Skin Cancer Unit (G300), German Cancer Research Center, Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. V.Umansky@dkfz-heidelberg.de.
authors.forename: Viktor
authors.initials: V
authors.lastname: Umansky
authors.affiliation: Laboratory of Cell Mediated Immunity, SAIC-Frederick, Inc., NCI-Frederick, Frederick, MD, USA.
authors.forename: Anatoli
authors.initials: A
authors.lastname: Malyguine
authors.affiliation: Department of Molecular Immunology and Toxicology, Center of Surgical and Molecular Tumorpathology, National Institute of Oncology, Budapest, Hungary.
authors.forename: Beatrix
authors.initials: B
authors.lastname: Kotlan
authors.affiliation: Laboratory of Clinical Analysis and Immunology, University Hospital Virgen de las Nieves, Granada, Spain.
authors.forename: Natalia
authors.initials: N
authors.lastname: Aptsiauri
authors.affiliation: Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
authors.forename: Michael R
authors.initials: MR
authors.lastname: Shurin
mesh_terms: D000818:Animals; D015972:Gene Expression Regulation, Neoplastic / Q000276:immunology; D006801:Humans; D006814:Hungary; D007167:Immunotherapy; D007391:International Cooperation; D015166:Monitoring, Immunologic / Q000639:trends; D008991:Monitoring, Physiologic; D009369:Neoplasms / Q000276:immunology / Q000628:therapy; D057170:Translational Research, Biomedical